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ABSTRACT 
 
SYED, BIBIASMA, R., Master of Public Health: January: 2020, Public Health  
Title: Prevalence of At-Risk Marriages among Couples Attending Premarital Screening 
(PMS) Programs: A Systematic Review and Meta-Analysis 
Supervisor of Thesis: Dr Karam, T, Adawi. 
Introduction/Background: Hemoglobinopathies are among the most common inherited 
genetic diseases. The World Health Organization estimates that at least 5% of the world’s 
population are carriers for hemoglobinopathies (2.9% for thalassemia and 2.3% for sickle 
cell disease). Programs like Premarital Screening (PMS) have been developed in most 
Middle East countries on a mandatory basis to reduce at-risk marriages by providing 
counseling after a confirmed “genetic carrier” state for hemoglobinopathies. 
Aim/Objective: The aim of this systematic review and meta-analysis was to estimate the 
prevalence of at-risk marriages globally and see the variation by region, income level, 
ethnicity, study period, implementation year of PMS program, study design and 
consanguinity proportion. 
Methods: Different databases such as PubMed, Science Direct, and Scopus were searched 
systematically by using key terms and MeSH Terms. Studies from Google Scholar and 
reference lists of studies were also collected, and the author extracted all relevant data. Two 
reviewers independently conducted quality assessment by using Hoy et al (2012) risk of 
bias tool. Quality effects model (QEM) was used due to considerable heterogeneity 
observed between studies. Subgroup analysis and sensitivity analysis were also performed 
for assessing the causes of heterogeneity.  
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Results: a total of 15 studies were included in this meta-analysis. The overall pooled 
prevalence of at-risk marriages among total couples at-risk was 64% (95% CI: 49%- 78%). 
Estimates of several subgroups were found to be different as compared to the overall 
pooled estimate. Funnel plot and Doi plot indicated the presence of publication bias. 
Sensitivity analysis including only studies with low risk led to a pooled estimate of 52% 
(CI: 46%, 57%) and indicated absence of publication bias.  
Conclusion and Recommendations: The pooled estimates varied widely and there was a 
substantial heterogeneity among studies, therefore, there is a need for more well-designed 
studies across different countries. Moreover, the importance of the quality of counseling 
sessions should be stressed and combined with efforts in other community sectors, such as 
high schools where students can attain high knowledge regarding genetic diseases before 
the age of marriage. 
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CHAPTER 1: INTRODUCTION 
1.1 Background 
The Global Report on Birth Defects published in 2006 ranked 193 countries with 
respect to the rates of highest birth defects. Countries from the Middle East region were 
among the top with Sudan being the first (82 birth defects per 1000 live births), followed 
by Saudi Arabia (81.3 birth defects per 1000 live births) then United Arab Emirates, Iraq, 
Kuwait, Oman and Syria. Qatar was ranked as sixteenth with 73.4 birth defects per 1000 
live births. Moreover, the report stated the lowest rate of birth defects in France with 39.7 
per 1,000 live births (1). Common birth defects include congenital heart defects, neural 
tube defects, hemoglobinopathies such as thalassemia and sickle cell disease(SCD), down 
syndrome and glucose-6-phosphate dehydrogenase (G6PD) deficiency (1).  
Globally, the prevalence of some autosomal recessive single gene birth defects such 
as sickle cell disease, cystic fibrosis and glucose-6-phosphate dehydrogenase (G6PD) 
deficiency is higher in developing countries, due to high rates of consanguineous marriages 
(2). As a result, consanguinity increases the chances for children of consanguineous parents 
to inherit identical copies (being homozygous) for recessive alleles due to the shared 
ancestor between the parents (autozygosity). In other words, consanguinity is defined as a 
marriage between individuals who are related to each other as second cousins or closer.           
 Evidence has shown that children with consanguineous parents are at 2.5 times 
higher risk of having autosomal-recessive diseases such as thalassemia, sickle-cell anemia 
and cystic fibrosis as well as congenital diseases/malformations (2).  
Due to high burden of several recessive genetic diseases, especially beta-
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thalassemia, in the Middle East, several countries have implemented mandatory premarital 
screening programs (PMS) to reduce at-risk marriages and the prevalence of such diseases 
and thus their medical and economic burden (3). The PMS mandatory programs started in 
the Mediterranean region with Cyprus being the first country implementing a PMS 
program for beta-thalassemia in 1973 (3). In other countries such as Jordan, Saudi Arabia 
and Bahrain, the PMS program was mandated in the beginning of the 21st century (3). 
Similarly, in 2009, premarital screening program was implemented in Qatar (3).  
Further, for the purpose of this study, “at-risk marriage” refers to a prospective 
couple carrying an abnormal gene (both carriers) and therefore, transmitting the genetic 
disease to their future offspring.  
In light of the above-mentioned burden of genetic disorders globally and regionally, 
there is a wide gap in the literature regarding the effect of the PMS programs and whether 
such programs reduce the incidence of hemoglobinopathies through reducing at-risk 
marriages. In other words, the effect of PMS programs in reducing at-risk marriages has 
not been evaluated globally in terms of systematic review and meta-analysis. Therefore, in 
the context of the paucity of data on at-risk marriages from PMS programs, this study helps 
to fill the existing scientific gaps with the following aim, objectives and research questions. 
 
1.2 Aim 
To assess systematically the prevalence of marriages among at-risk couples 
undergoing premarital screening program and to explore factors associated with variation 
in prevalence. 
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1.3 Objectives 
• To systematically review the global proportion/prevalence of marriages among at-
risk couples who underwent PMS program and counseling 
• To quantify the global prevalence of marriages among at-risk couples using meta-
analysis  
• To explore the potential factors associated with variation in the prevalence of 
marriages among at-risk couples with respect to ethnicity (Arab versus non-Arab), 
geographical region, income-level, availability of prenatal diagnosis (PND) 
services, consanguinity among at-risk couples, and year of program 
implementation. 
 
1.4 Research Questions 
 
• What is the global prevalence of at-risk marriages among couples who underwent 
PMS programs and counseling? 
• What are the potential factors associated with the prevalence of marriages among 
at-risk couples globally? 
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CHAPTER 2: LITERATURE REVIEW 
The literature review is divided into eight sections that discuss the epidemiology of 
genetic diseases globally with focus on hemoglobinopathies, genetic diseases and its 
association with consanguinity, implementation of premarital screening programs, 
mandatory or voluntary aspects of these programs, counseling services in PMS programs, 
knowledge and attitude of PMS and a final section based on studies on PMS. 
2.1 Genetic Diseases Epidemiology 
Globally, the incidence of genetic diseases was reported to be 5.32% in births based 
on a followed up study over 25 years (4). This includes common autosomal recessive 
disorders such as thalassemia, sickle cell disease and glucose 6 phosphate 
dehydrogenase(G6PD) deficiency and cystic fibrosis. Available data at global level 
between 1952 and 1983, estimated the prevalence of cystic fibrosis at 232.5 per million 
births and the prevalence for thalassemia at 32.5 per million births (4). Additionally, based 
on the World Health Organization (WHO) estimates, 2.9% of the world’s population is 
affected by beta-thalassemia, which affects the health of the population worldwide 
negatively and gives rise to many challenges on health care system and resources globally 
(5).  
Specifically, in the Middle East region, the prevalence of beta-thalassemia is 
considered high; 1-15% of the population are carries of the trait (i.e. have a single copy of 
the disease allele) (6)(7). However, in the Arab World, studies suggesting the percentages 
of beta-thalassemia carriers vary from one country to another but in general, the range is 
between 2.0% to 10.0% (7). For example,  in the Gulf region, a study carried out in Saudi 
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Arabia (5) on 15,72,140 men and women found that the prevalence of sickle cell was 45.1 
per 1000 persons examined, and this included 42.4 carriers and 2.7 cases. In case of beta-
thalassemia, the prevalence of positive beta-thalassemia among couples was 18.5 per 1000 
persons examined (including 18.0 carriers and 0.5 cases per 1000 persons examined).  
Another study from Gulf i.e. Oman reported the prevalence of sickle-cell and beta-
thalassemia among Omani children under age five years was 6% and 2% respectively (8). 
It has been reported that patients with hereditary blood disorders usually experience 
decreased academic performance and higher rates of absenteeism due to frequent 
hospitalization needs and follow up appointments(8).  
In addition, a study conducted in Qatar analyzed data of a sample of 3,275 patients 
from Hamad Medical Corporation that was collected between 1994-2000(9). The study 
showed that 30.4% of Qataris and 42.3% of non-Qataris had beta-thalassemia (trait, 
intermediate or major).  
It is evident from aforementioned percentages that not only genetic diseases are 
widely studied in the Middle East region, but such genetic diseases could be life-
threatening and expensive to treat as well. For example, it is estimated that the treatment 
for beta-thalassemia costs more than U$ 400,000 per person over a lifetime and cystic 
fibrosis costs U$ 9,400 per person per year. In the Arab world specifically, it has been 
estimated that the overall cost of almost all common genetic disorders is US$ 13 billion 
per year (2).  
2.1.1 Hemoglobinopathies 
Among the many types of genetic diseases, beta-thalassemia and sickle-cell disease 
are the two examples of hemoglobinopathies. The prevalence of beta-thalassemia 
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mutations ranges from <1% to 16%; it is 3.5%- 3.8% in South China, 3-4% in India, 1.5-
3% in North Africa and 4-11% in Middle East countries.  
Countries in the Mediterranean region also have high prevalence of beta-
thalassemia; For example, Cyprus was reported to have 17.2% prevalence, but the 
proportion dropped to 12.1% in the last two decades mainly due to implementation of 
prenatal screening (10). This is because, prenatal screening helps in identifying if the baby 
experiences any birth defects that could be a result of genetic disorder and therefore, 
prenatal screening might act as a preventative strategy due to termination of pregnancy(10).                
In addition, in Cyprus, the mean frequency of heterozygous thalassemia all over the country 
was reported to be 7.4% with extremely uneven distribution between low altitude (up to 
15%) fertile areas as compared to high altitude areas (11).  
As stated earlier, genetic diseases are known to be life-threatening for patients 
affected with it. For example, in developed countries, it has been estimated that thalassemia 
patients can survive for 25-55 years depending on the medical treatment’s compliance by 
the patient. On the other hand, in developing countries, due to insufficient medical 
treatment, most of the thalassemia-affected patients die before the age of 20 (12). 
Another common example of Hemoglobinopathies is Sickle Cell Disease. SCD is 
defined as a group of conditions that results from the inheritance of hemoglobin S (HbS). 
It is reported (13) that HbS allele was originally found to be distributed throughout the 
region of Sub-Saharan Africa, the Middle East, the Mediterranean area and India. The 
carrier rates for this disease range from 5% to greater than 40% in above mentioned regions 
(13). 
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2.1.1.2 Genetic Diseases and Consanguinity 
 The high prevalence of beta-thalassemia in the Middle East is usually attributed to 
the high proportion of consanguineous marriages which is estimated as 25 to 60% among 
first degree cousins (14). It has been reported that consanguineous marriages are favored 
in many Arab majority countries (14). There can be numerous factors that explains the 
attitude of several populations towards supporting consanguineous marriages. For 
example, previous sociological studies showed that consanguineous marriages increase 
stability, compatibility and strengthen family ties between the husband, the wife and the 
in-laws as well as help in allowing wealth and property to stay within the family (15).  
A study in Egypt indicated that men who had good educational and occupational 
status were considered as ‘valuable assets’ and were usually pressured to marry within the 
family (16). Moreover, evidence from a developing country like Pakistan shows that 
sociocultural factors rather than religion or economic reasons seem to be the major 
determinants of consanguineous marriages(17). These factors are regarded as advantages 
of consanguineous marriages and they include; “relatives more caring”, “relatives-known 
entity”, “easy adjustment for girls”, “tradition” and “strengthen family ties”. Furthermore, 
it has been estimated that such factors are acting as resistant to change (17). 
In terms of consanguinity rate in Qatar, a study conducted among 876 women 
(between 2004 and 2005) indicated that the rate of consanguinity among the study 
population was 51.0% while the rate of first cousin marriages was 26.7% (18). In another 
study(19) conducted in 2006 among Qatari females, the proportion of consanguineous 
marriages was reported to be 54% whereas the proportion of first-cousin marriages was 
34.8%. Similarly, in Saudi Arabia, the overall prevalence of consanguineous marriage is 
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56% while it is reported to be 33.6% between first cousins (20). 
In the Middle East countries, a more recent study in 2018 reported the percentages 
of consanguineous marriages as above 20%. For example, the prevalence of 
consanguineous marriages are: 42-67% in Saudi Arabia, 54% in Qatar, 40-54% in United 
Arab Emirates, 29-64% in Jordan, 21-33% in Egypt, 44-63% in Sudan, and 40-45% in 
Yemen (2). Consequently, due to high rates of consanguinity, findings from different 
studies in Arab countries suggest that percentages of beta-thalassemia carriers vary from 
one country to another but in general, the range is between 2.0 to 10.0% (7).  
2.1.1.3 Implementation of Premarital Screening (PMS) Programs 
Due to high rates of autosomal recessive disorders in the Middle East countries, 
various countries implemented mandatory premarital screening programs in order to 
reduce the incidence of such diseases, improve the population health and reduce the burden 
on the health service systems in these countries.   
First of all, Cyprus (a country in the Mediterranean region) implemented beta-
thalassemia Premarital Screening (PMS) program in 1973. This program proved to be very 
successful against reducing the beta-thalassemia rates from 51 in 1974 to 8 in 1979. The 
incidence further decreased after the program was mandated in early 1980s with zero 
affected births occurring between 2002 and 2007 (21).  Later, in Turkey (Denizli), Iran and 
Jordan, PMS was first implemented in 1995, 1997 and 2004 respectively(3). In Turkey, 
written regulations for the Fight against Hereditary Blood disease were established in 2002. 
Ministry of Health and Turkish National Hemoglobinopathy Council (TNHC) selected a 
total of 33 provinces that had high prevalence of severe hemoglobinopathies. A premarital 
screening program for hemoglobinopathies called the Hemoglobinopathy Control Program 
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(HCP) started in 2003 in these 33 provinces and it is running successfully since then (22). 
  Considering the Gulf countries, the PMS was implemented in Oman in 1999, in 
Saudi Arabia in 2004, in Bahrain in 2005, and in Kuwait in 2008. Similarly, PMS was 
implemented in Qatar and UAE in 2009 and 2011 respectively. It is worthy to highlight 
that in all Gulf countries, the program is provided on a mandatory basis except in Oman, 
where it is still provided as an optional free of charge service (3). One of the main uses of 
Premarital screening programs is that it can help prevent affected births if the couples at-
risk could be identified beforehand (23). Such programs gives the at-risk couples the wide 
range of possible options even if they proceeded to marry. This is because no single 
screening strategy provided in premarital counseling can work effectively to meet the needs 
of an entire population (24). 
 
2.1.1.3.1 Voluntary vs. Mandatory PMS 
Some of the countries in Mediterranean region (Cyprus, Italy and Greece) and 
Middle East (Turkey, Iran, Jordan, Palestine and most GCC countries) have made it 
mandatory for all couples to undergo premarital screening (25). The main aim of 
conducting such programs on a mandatory basis is due to high rates of consanguinity 
prevailing in middle east region that contributes to various genetic diseases particularly 
hemoglobinopathies (25). 
In China, the program is offered on a voluntary basis and some studies have 
investigated the participation rate among the general population in China. For example, a 
study conducted in China in 2013 (26) reported that the participation rate in the PMS 
program was 34.8%. Factors like higher age, residency and profession were found to be 
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associated with the participation of program (26).  
In Bahrain the screening was introduced as an optional service in 1993. A ten-year 
evaluation of the Bahrain’s PMS program in 2003 indicated that only 25% of the couples 
approached the screening service offered. Consequently, in 2005, a Royal decree of 
compulsory testing before providing marriage certificate was introduced that aimed to 
reduce the prevalence of hereditary diseases (27).  
On the other hand, in most other countries globally like Egypt, Canada, China, UK, 
India and Indonesia, these type of screening programs are done on a voluntary basis (25). 
2.1.1.3.2 Premarital Counseling Services 
Genetic counselling services are usually offered to those planning to marry and 
might be at risk of carrying some genetic diseases. These sessions are provided on a one-
to-one basis after a couple receives a “mismatch certificate”. The counselors usually 
provide information regarding carrier status for at-risk couples, also they provide 
counseling regarding preventative reproductive options such as prenatal diagnosis and pre-
implantation genetic diagnosis (PGD). Such services are useful for various defects in 
genes, and chromosomal abnormalities (28). 
However, there are certain challenges that may be faced by genetic counsellors 
while providing counseling to at-risk couples. These include high consanguinity rate, 
preventative reproductive options or termination of pregnancy, emotional and social 
impact on carrier women as well as complex molecular test findings (28).  
Evidence from Iran (24) shows that at the outset, the options for at-risk couples 
were limited to either marrying as planned, separating and finding a non-carrier partner, or 
favoring to postpone marriage or childbearing in the hope that there will be a better solution 
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in the future. However, it soon became evident from the reported experiences of the 
counselors that the population wanted to seek prenatal diagnosis option. This led to 
widespread ethical discussions which ended with a government decision in 1998 to allow 
the abortion of fetus before 16 weeks from the last menstrual period only if the fetus is 
known to be genetically affected (24).  
 
2.1.1.4 Knowledge and Attitudes of PMS:  
 
One of the aspects to understand the success or failure of PMS programs is through 
the knowledge and attitude among general population. This can be explained by the fact 
that knowledge and attitudes could be regarded as important attributes of decision-making 
among at-risk couples who underwent premarital counseling.  
There are many studies conducted regarding the knowledge and attitude of PMS 
especially in the Middle East region. For example, a study in Turkey (29) indicated that  
91% of the study participants were aware of the positive effects of PMS programs and that 
such screening can contribute to reduction of genetic diseases. However, the level of 
knowledge was inadequate when assessed for beta-thalassemia. Hence, 17.5% of the 
participants thought that thalassemia is contagious while 82.5% of participants had no idea 
or thought thalassemia is not contagious.  
Another study in Egypt assessed the knowledge level and attitude of medical and 
non-medical female students(30). It indicated that, a level of knowledge among medical 
female students categorized as ‘high’ was 32.3% as compared to non-medical students 
(21.0%). In addition, 54.7% of the medical students had positive knowledge regarding 
PMS as compared to 49.0% of non-medical students(30).  
  
   
12 
 
Similarly, due to recent implementation of PMS programs (where screening is 
either mandatory or voluntary) in the Gulf region, several studies were conducted in the 
region assessing the knowledge and attitude of subpopulations regarding PMS(8–11). Most 
of these studies were conducted in the Gulf region (mostly in Saudi Arabia), where 
knowledge and attitude of PMS was assessed among university students(33,35–44) as well 
as local population accessing health care in hospitals(32,34,45). For instance, a study 
conducted in Saudi Arabia in 2013 assessed the knowledge, attitude and satisfaction level 
of Premarital Screening and Genetic Counselling (PMSGC) program among participants 
attending governmental outpatient clinics. It showed that 80.5% of subjects had a low 
knowledge score (<15 score out of 40) while only 5.5% of the participants had satisfactory 
scores i.e. 20 out of 40(32).  
Another study in Oman, where the program is not mandatory at national level, 
explored the knowledge and attitude of university students towards PMS. It showed that 
most of the students (n=469; 79%) were aware about the availability of PMS program. 
Similarly, regarding the students’ attitude, the majority (n=540; 92%) thought that it is 
important to undergo screening and they were willing to do it. However,  only 53% of the 
participants were in favor of making the PMS program  mandatory for all pre-couples(38). 
Another study in Saudi Arabia assessed the knowledge and attitude of PMS among 
university students through self-administered questionnaire (n= 1000 students)(33). The 
results indicated that 94.0% (n=922) of participants believed that PMS program was a 
preventive measure and 77.1% of participants reported that these tests should be held 
before engagement(33).  
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In terms of general population, Binshihon et al (2018)  has conducted a study (34) 
on 1039 unmarried males and females from the general population to assess the knowledge 
and attitude of PMS programs in Saudi Arabia. The results revealed that 51.1% of the 
participants had poor knowledge scores (14 points out of 23) while only 20.5% had good 
scores (19 points out of 23). In addition, educational level was significantly associated 
with the knowledge score, where people with higher education were having better 
knowledge scores. Moreover, participants aged ≥ 25 years had higher knowledge score 
compared to those less than 25 years (p-value=0.005). In addition, participants with a 
family history of genetic disease had significantly higher knowledge scores compared to 
their counterparts (p-value<0.001). Regarding the attitude, 60.4% of participants had 
positive attitude towards PMS. Almost half of participants strongly agreed that getting 
incompatible results and completing the marriage is a wrong decision. Similarly, 40.0% of 
participants strongly agreed that PMS does not violate the personal privacy (34). 
A study done in Qatar (46) collected data between January 2013-May 2014 from 
hospital and primary health care centers chosen randomly with a total of 873 respondents 
(70%) out of 1246 initiated surveys. The questionnaire assessed the knowledge, attitude 
and practice of PMS program among married adults (Qatari nationals and Arab women) 
aged 18-40 years. The results indicated that there was no statistically significant difference 
between males and females regarding knowledge score of hemoglobinopathies (sickle cell 
anemia and thalassemia), homocystinuria, Human Immunodeficiency Virus (HIV), cystic 
fibrosis and hepatitis.  
Regarding the attitude of respondents towards PMS program, there was statistically 
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significant differences between males and females (p-value >0.05). Women were more 
aware of genetic diseases and the risks associated with genetics, and Sexually Transmitted 
Diseases (STDs). In addition, through stepwise multivariate regression analyses, the 
predictors for knowledge of PMS and some associated covariates were; social, religious, 
family or parental interventions, consanguinity, educational level, knowledge of genetic 
counseling, and love after adjusting for demographic variables such as age and gender (46). 
2.1.1.5 Studies on PMS: 
 
To sum up, there is a lack of research on prevalence of high-risk marriages 
regionally and globally. Most of the previous studies in the Middle East region focused on 
exploring the level of knowledge and attitude of PMS and the factors associated with it. 
Furthermore, a large body of research has been done on reporting the proportion of 
marriage cancellation rates among at-risk couples undergoing PMS counseling rather than 
the prevalence of high-risk marriage. These studies were mostly conducted in the Eastern 
Mediterranean region for the purpose of collecting data on the success of PMS programs. 
However, from a public health perspective, prevalence of at high-risk marriage should be 
addressed and flagged as a serious public health issue due to the high economic costs and 
human suffer of chronic and genetic diseases. 
There is a lack of research on the global prevalence of at-risk marriages and to the 
best of our knowledge, there is no study that addressed this issue at the global or regional 
levels. Therefore, the current study aims to assess systematically the prevalence of 
marriages among at-risk couples undergoing Premarital Screening (PMS) program and to 
explore factors associated with variation in prevalence. 
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CHAPTER 3: METHODS 
 
This is a systematic review and meta-analysis study design to assess systematically 
the prevalence of marriages among at-risk couples and quantitatively pool its prevalence 
while exploring factors associated with its variation.  
The aim of systematic reviews is to identify the eligible studies and quantitatively 
synthesize findings in a narrative manner. Moreover, it also includes the risk of bias 
assessment to assess internal and external validity of the included studies.  
On the other hand, meta-analysis is a quantitative, statistical method that pools the 
effect sizes of papers identified through systematic review. By calculating the pooled 
estimate of those couples approaching marriage, a critical outcome is obtained. A well-
conducted meta-analysis also helps to investigate the sources of heterogeneity or variability 
of results among the studies. Heterogeneity might include both statistical and clinical 
sources. To explain the sources of variability in the included studies, sub-group analysis 
and sensitivity analysis can be conducted (47).  
In this study, the quality of identified studies were assessed using Hoy et al (2012) 
risk of bias (ROB) tool, developed specifically for evaluation of risk of bias associated with 
prevalence studies (48). For the meta-analysis, MetaXL software (version 5.3) (49) was 
used to estimate the overall pooled estimate as well as to conduct the sensitivity and sub-
group analysis. 
 The scores obtained from ROB assessment tool, used for pooling the prevalence 
(proportion of marriage among at-risk couples), were also used as inputs for Quality Effects 
Model (QEM) invented by Doi & Thalib (50). 
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The recommendations from the Preferred Reporting Items for Systematic Review 
and Meta-Analysis (PRISMA) were followed and used as a guide to report this systematic 
review and meta-analysis (51). In addition, the reporting guidelines from Meta-analysis of 
Observational Studies in Epidemiology (MOOSE) were also followed as guidance for this 
meta-analysis (52). 
3.1 Search Databases 
The electronic databases that were searched systematically included PubMed, 
Science Direct, Scopus and Google scholar. These databases were chosen as they are the 
most relevant in terms of publishing on health and social issues. All relevant studies starting 
from 2000 up to September 15, 2019 were identified.  
3.2 Search Strategy 
The search strategy was developed including a comprehensive database search 
using key terms: Premarital examination* OR pre-marriage counsel* OR Pre-marriage 
counseling program* AND evaluation OR outcome* OR result*. In addition, relevant 
Medical Subject Heading (MeSH) terms were included in the search strategy. We used the 
above mentioned terms and combined them with ‘AND’ and ‘OR’ in accordance with 
search engine specifications. Additional studies were identified through manual search of 
the reference lists of the relevant articles. There has not been any systematic review or 
meta-analysis published on the prevalence of marriages among at-risk couples; hence, 
searching included review articles to identify any related studies. Furthermore, the search 
was limited to articles in English language. All duplicate studies, obtained from different 
databases, were removed by Zotero reference manager program. 
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3.3 Eligibility Criteria 
The following inclusion criteria were developed to identify and select the relevant 
or eligible research articles: 
• Published in English language 
• Peer-reviewed studies 
• Cohort, cross-sectional, case-control and case series  
• Both prospective and retrospective studies were included 
• Studies with prevalence/proportion of at-risk marriages in cohort or population-
based studies of couples screened. 
3.4 Exclusion Criteria 
The excluded studies were: 
• Experimental studies and narrative reviews  
• Studies that reported the prevalence or incidence of beta-thalassemia trait or disease 
among the children of at-risk couples 
• Studies where cancellation rates of marriages were not reported  
3.5 Identification of Publications 
A total of 15 published studies were identified based on our inclusion and exclusion 
criteria. The 15 studies which reported on the prevalence of at-risk marriages, were peer-
reviewed, and were published between 2000 and 2016. Overlapping or duplicate studies 
were removed and a PRISMA flowchart was generated (51). (Figure 1) 
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Figure 1: PRISMA Flowchart for Search Strategy
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3.6 Data Extraction 
Data was extracted from the 15 studies by using a standardized form including: 
author, year, city (country), study design, total couples screened, couples found at risk and 
carrier couples who married despite receiving counseling. Furthermore, data on some 
prespecified characteristics from included studies were also extracted in case of possible 
detection of heterogeneity among studies. A qualitative narrative summary of the 15 
included studies is presented in the result section, 
3.7 Risk of Bias Assessment 
The quality of each of the included studies was assessed independently by the 
researcher and a second reviewer. The two reviewers also assessed independently and in a 
blinded fashion the risk of bias of the 15 studies, to ensure that the criteria were applied 
consistently, and a consensus reached according to the recommendations provided by 
Cochrane Handbook for Systematic Reviews of Interventions (53).  
The two reviewers independently used Hoy’s criteria  (2012) (48) that is explicitly 
designed to assess risk of bias in prevalence studies. The tool consists of two sections, 
internal validity and external validity. Internal validity refers to the degree to which the 
design and conduct of a study have used methodologically sound steps to obtain minimum 
possible bias. On the other hand, external validity refers to the ability of the study to 
generalize its results to a larger population (54).  
The Hoy’s risk of bias tool consists of a total of 10 components (Figure 2). The first 
three components assess the risk of selection bias, item 4 assesses non-response bias and 
items from 5 to 9 assess measurement bias in a study. In addition, the last component of 
Hoy’s tool  is related to the analysis which implies that the numerator(s) and denominator(s) 
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related to parameter of interest should be appropriate(55). For each criterion, the risk of bias 
was assessed either “low risk” or “high risk” based on “yes” and “no”. Low risk was 
classified as “yes” and was given a score of 1, while high risk was classified as “no” and 
was given a score of 0.  If the particular criteria mentioned in Hoy’s tool was unclear in a 
study, it was reported as “high risk” (55). The scores, across all components were summed 
up to get a final score out of 10 for each study. Furthermore, Hoy et al.’s (2012) 
classification was used to classify the 15 studies as high, moderate or low risk of bias. 
Scoring of 9 and above means having a low risk of bias, while a score of 6 to 8 is moderate 
risk of bias and having a score of 5 or less is categorized as having high risk of bias. 
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Figure 2: Hoy et al.’s (2012) Items of Risk Assessment Bias 
 
 
The agreement between the two raters was assessed using proportion of agreement 
(po) and the Kappa statistic. The proportion of agreement (po) is the raw percentage of the 
number of times the two raters agree. However, there is disadvantage of using po because it 
does not take into account chance agreement, the distribution of agreement as well as 
ordering of agreement in terms of ordinal data(56). On the other hand, the advantage of 
using Kappa statistic is that it takes into account chance agreement. Kappa values range 
from -1 to +1, where 0 or less is regarded as poor agreement, 0.01 to 0.20 as slight, 0.21 to 
0.40 as fair, 0.41 to 0.60 as moderate, 0.61 to 0.80 as substantial, and 0.81 to 0.99 as almost 
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perfect agreement (57).  
An agreement of 80% was achieved between the scores of the two reviewers, using STATA. 
Such high percentage of agreement shows that there is substantial agreement between the 
reviewers in terms of rating. Moreover, the Kappa statistic was used to assess agreement 
where a Kappa coefficient of 0.71 (CI: 0.67, 0.78) was obtained (Table 1). This showed 
substantial agreement because kappa value (0.71) lied between 0.61 and 0.80(53). 
Discrepancies between the two reviewers were resolved by discussion. The final quality 
assessment results for each included study are reported in Table 2. 
 
Table 1: Kappa Agreement between the Two Raters for Quality Assessment  
Agreement 
 
Expected 
Agreement 
Kappa Standard 
Error 
Z P-value 95% CI 
80% 30.22% 0.7134 0.1508 4.73 <0.001 (0.672, 0.783) 
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Table 2: Methodological Quality Assessment Using Hoy et al (2012) Tool 
 External Validity Internal Validity   
Author & Year 1 2 3 4 
 
5 6 7 8 9 10 Score Risk of bias 
Tamhankar et al (2009) No No No Yes Yes Yes Yes No Yes Yes 6 High 
Memish et al (2011) Yes Yes Yes No Yes No Yes Yes Yes Yes 8 Intermediate 
Karimi et al (2007) No Yes Yes Yes Yes Yes Yes Yes Yes Yes 9 Low 
Zeinalian et al (2013) Yes No Yes Yes Yes Yes Yes Yes Yes No 8 Intermediate 
Al Sulaiman et al (2010) No No No No Yes Yes No Yes No Yes 4 High 
AlHamdan et al (2007) Yes Yes Yes No Yes No Yes Yes Yes Yes 8 Intermediate 
Al-Allawi et al (2013) No Yes Yes No Yes Yes Yes Yes Yes Yes 8 Intermediate 
Samavat et al (2004) Yes Yes Yes Yes Yes Yes Yes No Yes Yes 9 Low 
Salama et al (2016) No Yes Yes Yes Yes No No Yes Yes Yes 7 Intermediate 
Almutawa et al (2009) Yes Yes No Yes Yes Yes Yes Yes Yes Yes 
 
9 Low 
Tarazi et al (2007) No Yes Yes Yes Yes Yes Yes No Yes Yes 8 Intermediate 
Khorasani et al (2008) No Yes Yes Yes Yes Yes Yes Yes Yes Yes 9 Low 
Alsuwaidi et al (2012) Yes Yes Yes No Yes No Yes Yes Yes Yes 8 Intermediate 
Keskin et al (2000) No Yes Yes Yes Yes Yes Yes Yes Yes Yes 9 Low 
Guler et al (2010) No Yes Yes Yes Yes Yes Yes Yes Yes Yes 9 Low 
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3.8 Statistical Analysis 
For statistical analysis purposes, MetaXL software version 5.3 (50) was used to 
calculate the overall pooled effect size via quality effects model (QEM).  
QEM was developed by Doi & Thalib (2008) and is used, especially, when 
significant heterogeneity is detected (50). The main difference between the random-effects 
and quality-effects weights is that the former lacks to provide assessment of differences in 
study quality (50). In QEM, bias adjustment is based on measured methodological 
heterogeneity between studies, which results in a greater clinical relevance as well as helps 
to avoid the artificial inflation in variance which is otherwise seen in the random effects 
model (REM).  
To evaluate the statistical heterogeneity, Cochrane Q statistic (chi-square test) and 
Higgin’s I-squared (I2) statistics were used (58). Cochran’s chi-squared test is used  to assess 
if the variation found across studies is solely due to chance; .a p-value less than 0.05 is used 
to represent statistically significant heterogeneity (53). On the other hand, Higgin’s I-
squared (I2) statistics is a quantitative indicator which is used to estimate the proportion of 
variance between studies that could be due to statistical heterogeneity rather than chance 
alone(53)(58). An I2 value of 25% represents low heterogeneity, 26-50% represents 
moderate heterogeneity, 51-75% represents substantial heterogeneity while an I2 value of 
76-100% represents high heterogeneity (53)(58).  
Additionally, based on the above-mentioned tests and percentages, the detection of 
high heterogeneity would imply the uncertainty in our estimates or a risk of bias in study 
meta-analysis results. 
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In estimating the pooled effect size, prevalence (proportion) of at-risk marriages 
from each study and its quality score were considered. In addition to QEM, random effect 
models were also used for sub-group analysis based on Cochrane group recommendations 
of using REM when a substantial heterogeneity across studies is detected. Sensitivity 
analysis and sub-group analysis were also conducted in order to investigate the causes of 
heterogeneity. For sub-group analysis, specifically for income level of countries, the 
included studies were divided into World Bank specified income levels (59). In order to test 
for statistical significance differences between study subgroups, their confidence intervals 
were drawn against each other and compared for any overlapping. 
Further analyses were performed to examine publication bias through Funnel plot 
and Doi plot. A Doi plot is a new method of detecting publication bias and was developed 
due to subjective nature of scatter plots in funnel plots. In order to quantify the extent of 
asymmetry, an LFK index is used and the closer the value is to zero, the more symmetrical 
would be the plot (60).  
3.9 Ethical Considerations 
This study was approached by Qatar University Institutional Review Board (IRB) 
under approval number QU-IRB 1113-E/19. 
3.10 Source of Funding 
This project has not been funded by any partner or organization.   
3.11 Registration 
The details of this study were registered in PROSPERO and the preliminary 
reference number provided was, 151490. 
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CHAPTER 4: RESULTS 
4.1 Qualitative Summary 
The search strategy yielded a total of 375 articles whereas another 22 articles were 
identified through Google Scholar and reference lists of related articles. Based on the 
eligibility and inclusion/exclusion criteria, a total of 15 studies were included in the meta-
analysis as shown in Figure 1. Of these, 4 were conducted in Saudi Arabia, 4 in Iran, and 2 
in Turkey. In addition, one study was found in each of the following countries: Iraq, India, 
Bahrain, United Arab Emirates (UAE), and Palestine (Figure 3). Premarital screening 
programs (PMS) are provided on a voluntary basis in India, while it is mandatory for all 
other countries stated above.  
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Figure 3: Geographical Location of the Studies Included for Meta-analysis 
 
 
In terms of study designs, four studies used a cross-sectional design (reporting on 
point period), while one study used an unmatched case-control design. Moreover, the 
remaining 10 studies were retrospective population-based study designs reporting on period 
prevalence. 
The 15 studies varied in the number of participants included (couples screened), 
which ranged from 15 to 10,298 couples. The total sample size of our meta-analysis was 
33,540 couples obtained by pooling the 15 studies’ participants. Table 3 highlights the 
characteristics of the included studies in terms of study design, total couples screened, study 
period, diseases screened, PND data as well as implementation year of program.  
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Table 3: Characteristics of the Included Studies 
Author & 
Year 
City/Country Study 
Period 
Study Design Couples 
screened 
Diseases  
screened 
Prenatal 
Diagnosis 
data 
Implementation 
year 
Alsuwaidi  
et al (2012) 
Saudi Arabia 2005-2006 Unmatched 
Case control 
4,444 SCD,  
𝛽-Thalassemia 
& G6PD 
 
- 2004 
Memish et 
al (2011) 
Saudi Arabia 2004-2009 Retrospective 786,070 SCD &  
𝛽-Thalassemia 
 
- 2004 
Al Sulaiman 
et al (2010) 
Saudi Arabia 2007 Cross-
sectional 
129 SCD &  
𝛽-Thalassemia 
 
- 2004 
AlHamdan 
et al (2007) 
Saudi Arabia 2004-2006 Cross-
sectional 
207,333 SCD &  
𝛽-Thalassemia 
 
- 2004 
Zeinalian et 
al (2013) 
Isfahan, Iran 1992-2010 Retrospective 703,082 𝛽-thalassemia 
 
Available 1997 
Khorasani et 
al (2008) 
Mazandaran, 
Iran 
1993-2006 Retrospective 279,936 𝛽-thalassemia 
 
Available 1997 
Karimi et al 
(2007) 
Southern Iran 1995-2004 Retrospective 1,038,371 𝛽-thalassemia 
 
Available 1997 
  
   
29 
 
 
Author & 
Year 
City/Country Study 
Period 
Study Design Couples 
screened 
Diseases  
screened 
Prenatal 
Diagnosis  
data 
Implementation 
year 
Samavat et 
al (2004) 
Iran 1997-2001 Retrospective 2,729,000 𝛽-thalassemia 
 
Available 1997 
Salama et al 
(2016) 
Ras Al-
Khaimah, 
UAE 
2008-2015 Retrospective 8913 SCD & 𝛽-
Thalassemia 
 
- 2009 
Almutawa 
et al (2009) 
Bahrain 2006 Cross-
sectional 
1,070 SCD, 𝛽-
Thalassemia & 
G6PD 
- 2005 
Al-Allawi et 
al (2013) 
Northeastern 
Iraq 
2008-2012 Retrospective 54,132 SCD & 𝛽-
Thalassemia 
 
Available 2008 
Tarazi et al 
(2007) 
Gaza strip, 
Palestine 
2001-2005 Retrospective 19,712 𝛽-thalassemia 
 
- 2000 
Guler et al 
(2010) 
Kahramanmar
as, 
Turkey 
2006-2009 Retrospective 24,062 SCD & 𝛽-
Thalassemia 
 
- 2002 
Keskin et al 
(2000) 
Denizli, 
Turkey 
1995-1999 Retrospective 9,902 SCD & 𝛽-
Thalassemia 
 
Available 1995 
Tamhankar 
et al (2009) 
India 2003-2007 Cross-
sectional 
334 𝛽-thalassemia Available - 
Abbreviations: SCD: Sickle Cell Disease; UAE: United Arab Emirates 
-: Not available 
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4.2 Study Characteristics 
A narrative review describing 15 studies included in the meta-analysis is provided 
below. All the included studies were from the Middle East region except two studies from 
Turkey and one study from India. 
4.2.1 Studies in the Gulf Region 
From the GCC region, studies reporting the prevalence of at-risk marriages were 
from Saudi Arabia, United Arab Emirates (UAE) and Bahrain. 
4.2.1.1 Saudi Arabia 
In Saudi Arabia,  a case-control study was conducted (61) using the results of the 
first two years of program implementation (i.e. 2004 to 2006). A total of 4,444 at risk 
couples were identified during the 2-year period and marriage decision was known for 
2,375 while it was unknown for 2,069 couples. Out of 4444, around 2375 couples had their 
marriage decision known to Ministry of Health (MOH); on the other hand, 1135 couples 
were untraceable while the remaining 934 couples (sampling population) were categorized 
as with ‘unknown marriage decision’. The last category of 934 couples was either 
categorized as “did not marry” with 110 couples or “did-marry” with 824 couples. 
However, a required sample size of 582 couples (out of 934) was calculated for this case-
control study; 104 cases, who agreed to participate, and 478 controls, who were chosen 
randomly.  
Cases and controls were at-high risk marriages, but cases were defined as those 
“who did not marry” while controls were defined as “those who did marry”. The study 
showed that 37.2% of the control group got married due to “wedding already arranged/non-
cancelable”, while 12.1%  due to “familial commitment/pressure” (61). In addition, family 
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dependent individuals were more likely to marry than those who were financially 
independent (OR=1.1). Similarly, low-income participants were also less likely to marry 
than high-income participants with OR=1.26 (61). 
Another Saudi Arabian study, a retrospective population-based study, (5) assessed 
the six-year (2004-2009) outcome of the national premarital screening program for 
hemoglobinopathies (-thalassemia and Sickle cell disease). Of 1,572,140 couples, 70,962 
(4.5%) were found to be carriers or cases for sickle cell disease; while 29, 006 (1.8%) were 
positive (carriers or cases) for -thalassemia. It was also estimated that the annual 
prevalence of -thalassemia was 18.5 per 1000 examined persons while for sickle cell 
disease, the prevalence was 45.1 (42.4 for carriers and 2.7 cases) per 1000 persons 
examined. Among 5,370 at-risk couples, 3,945 couples(73.5%) got married despite 
undergoing the screening and counseling (5). 
Another follow-up survey (62) on at-risk couples was conducted in Saudi Arabia 
that involved a structured questionnaire for couples who had underwent premarital 
screening two years ago and were found to be at-risk for sickle cell disease or -
thalassemia. Out of the129 couples at-risk, 127 (98%) had proceeded with the marriage. 
Additionally, culture pressure was reported as the main reason in more than 48% of the 
couples while around 83% (107) of these couples appreciated the concept of genetic 
counseling.  
Another cross-sectional population-based study(63) evaluated the screening 
program of -thalassemia in Saudi Arabia between 2004 and 2005. During this two-year 
period, 207,333 couples were screened for hemoglobinopathy (-thalassemia & sickle cell 
  
   
32 
 
disease) and 4444 were reported as “high-risk”. Further, 2,375 of at-risk couples were 
followed up to collect data via a telephone survey. The results showed that 2,128 (89.6%) 
of those at-risk couples got married with their partners though the option of prenatal 
diagnosis was practically unavailable in the “existing” healthcare system at that time. On 
the other hand, if this option was available, the option of abortion would either be 
unavailable or unacceptable to families due to social and/or religious reasons (63).  
4.2.1.2 United Arab Emirates (UAE) 
A  retrospective population-based study (64) was conducted in Ras Al-Khaimah, in 
the United Arab Emirates, based on the premarital screening records of all couples who 
applied for marriage during the period 2005 to 2008 . Out of 17,826 individuals who were 
screened for hemoglobinopathies, 4.02% (717 individuals) were tested positive. In 
addition, the hemoglobinopathy trait was found to be more prevalent than the disease. 
Among the 8,913 couples who were issued incompatibility certificate, 28 (0.31%) were 
declared high risk. It was also reported that the rate of consanguinity among those at-risk 
couples was 70%. All the couples who were at risk (100%) continued for this 
hemoglobinopathy-risky marriage (64).  
4.2.1.3 Bahrain 
A cross-sectional study in Bahrain (27) explored the results  of premarital 
counseling of hemoglobinopathy carrier couples, who received premarital services.  Data 
was collected from 1,070 individuals between 1st April and 15th May 2006. The study 
showed that there were 30 couples with mean age of 25.7 years, and carriers to 
hemoglobinopathy, who were referred to genetic counseling. However, 17 couples (56.7%) 
continued with marriage despite the counseling and knowing their at-risk status. The study 
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concluded that the current policy of premarital screening is not successful in discouraging 
the at-risk couples (27).  
 
4.2.2 Levant Countries 
Levant countries is a term referred to a large geographical area situated in the 
Eastern Mediterranean region consisting of Iraq, Syria, Lebanon, Cyprus, Turkey (Hatay 
province), Israel, Jordan ad Palestine(65). From the Levant countries, the data on 
prevalence of at-risk marriages was reported from Iraq and Palestine. 
4.2.2.1 Iraq 
In Iraq, Northeastern part, (66) a total of 108, 264 individuals (54,132 couples) were 
screened during a 5-year period for -thalassemia and SCD. There were 130 couples at risk 
and most of them (n=105, 80.7%) proceeded with the marriage despite the counseling 
received. PND services were available for the couples; and the study showed that selective 
termination was chosen in 10 of the affected fetuses (66).  
4.2.2.2 Palestine 
In Palestine, a study examined the impact of a mandatory premarital screening test 
for -thalassemia before issuing a certificate marriage, between 2001and 2005 (67). During 
this period, a total of 122 couples were carriers for -thalassemia; however, 45.9% (56) of 
them continued with the marriage in spite of the counseling received. Moreover, 3 
thalassemia births occurred among those who had proceeded to marry. 
4.2.3 Iran 
In Iran,  a total of 703,082 couples were screened for -thalassemia during 1992- 
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2010 (68). Using these data, a retrospective population-based study showed that 1,317 
(0.19%) couples were classified as high-risk for -thalassemia and 4,412 were classified 
as “suspected couples”. Out of these two at-risk groups (a total of 5729 couples), 78.5% 
(n= 4497 couples) proceeded to marry their partners despite known status. This means that 
only 21.5% (n= 1232) of the couples cancelled their planned marriages. According to the 
study, prediction of prevalence of -thalassemia trait has becomes more complex due to 
high rate of consanguineous marriages (30-80%) among Iranians  (68). 
Another retrospective population-based study in Iran (69) evaluated the 13-year 
(1993-2005) premarital screening program for -thalassemia in the province of 
Mazandaran. A total of 279,936 couples were screened, 3,329 of these couples were at-risk 
for -thalassemia, of whom, 1826 couples (55%) decided not to marry. Those who married 
received special advice for the prevention of unplanned pregnancy as well as for prenatal 
diagnosis during pregnancy. It has been observed that the number of at-risk couples have 
increased over the years; from 12 in 1993 to 453 in 2005. This increase could be due to the 
mandatory nature of the program in 1998; since the program screens for more people now, 
the number of captured cases increases compared to the past. 
An Iranian study (70) assessed the 10-year outcome of -thalassemia screening 
program in Southern Iran. A total of 1,038,371 couples were screened, of whom 5,182 
(0.4%) couples found to be “carriers” for -thalassemia trait. More than half (54%) of these 
carriers (at-risk couples) continued with marriage.  
Another study (24) from Iran investigated the national thalassemia screening 
program over a period of five years (1997-2001), where a total of 2.7 million prospective 
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couples were screened. Of these 10,298 couples were at-risk and 5431 (53%) proceeded to 
marry despite knowing their carrier status. The study also stated that since the development 
of the DNA laboratory network in Iran, there has been a dramatic increase in the number 
of couples seeking PND (69). 
4.2.4 Turkey 
In Turkey a study was conducted in the province of Kahramanmaras (71), where 
the mandatory screening program for -thalassemia and sickle-cell anemia (SCA) trait took 
place in 2002. The study presented the results of the 3-year program (2006 to 2009). A 
total of 24,062 couples were screened during this period, where 17 were found to be carriers 
(at-risk couples) for -thalassemia. The decision to marry or not marry was left to the 
couples themselves after receiving counseling. The results indicated that 14 (82%) out of 
17 couples did not marry their partners. Moreover, the other three couples were informed 
about the prenatal diagnosis.  
Another study in Turkey(72) was conducted in Denizli, which is the first province 
that had implemented PMS program since 1995, evaluated the 4-year (1995-1999) program 
results of screening  -thalassemia and SCD. The couples who were found at high-risk 
were also offered prenatal diagnosis and termination of pregnancy services. Among 9,902 
couples (19,804 individuals) tested during the study period, 15 couples were carriers (both 
partners) of -thalassemia trait. After the couples received counseling, only two (13.3%) 
of the 15 planned marriages were cancelled;  prenatal diagnosis was sought by six (46.1%) 
of the 13 couples (72).  
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4.2.5 India 
In India, the premarital screening program is not implemented as a mandatory 
program but rather on a voluntary basis. A study (73) recruited samples in three steps; first 
group were prospective couples of the extended family member (EFM) of patients who 
were affected with thalassemia or hemoglobinopathy. The prospective couples who were 
planning to marry were given counseling and screened. The second group was recruited 
from the anemia cases seen at the Out-Patient Department (OPD) of the hospital as well as 
cases of anemia amongst university students. Carriers were counseled and were given the 
chance of getting their prospective couples screened on a voluntary basis.  
The third group included adults from districts with the highest number of 
cases/carriers and were selected for the College Group (CG) screening component. Single 
adults were counseled and screened for thalassemia, during a week-long camp in the 
vicinity of a university. Carriers were called for a second visit and informed about the need 
of getting their prospective couples screened before marriage. Carriers were also informed 
to report any cancellation of marriages, or other issues faced at the social level.  
The results indicated that a total of 204 couples were at-risk of -thalassemia out 
of the three groups. The prospective couples were given counseling and informed about 
the risk of having children born with thalassemia. However, almost all i.e. 202 (99%) of 
the 204 couples proceeded with the marriage plans (73). 
4.3 Overall Summary of Studies: 
It was evident that most of the large studies (with big sample size) were conducted 
in Iran, i.e. 4 studies (24,68–70), and 2 studies were carried out in Saudi Arabia (5,63). 
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Among the demographic variables, age was reported in the included studies, e.g. mean or 
median age of the overall study sample or mean or median age for males and females 
separately. Mean age of the participants in two studies (70,72) for males ranged from 22.5 
to 24.5 years while for females, it ranged from 18.2 to 20.8 years. Similarly, in a study 
from Turkey(71) and Bahrain (27), the mean age of study sample was 24.9 and 25.9, 
respectively. Only one study (62) reported the age range for males as 21 to 52 (median 26 
years) and for females as 17 to 31 (median 23 years). In addition, very limited data was 
provided based on the educational level of study participants. In a case control study (61) 
done on at-risk couples during 2005-2006,  64.6% (n=309) of at-risk couples who married 
each other had secondary education or lower. Interestingly, the prevalence of at-risk 
marriages was high: 82%. On the contrary, a post marital follow up survey (62) reported 
the prevalence of at-risk marriages as 98%, and the study showed that 72% (n=93) had 
educational level higher than 12 years.  
There were variations among studies in terms of length (years) of outcome 
assessment and thus, the study sample varied accordingly. The study period was two years 
or less for four studies, three to five years for six studies, 6-10 years for three studies, and 
11-20 years for the remaining two studies. Considering the premarital screening- related 
diseases in the included studies, -thalassemia was reported in six studies, both -
thalassemia and sickle cell disease (SCD) were reported in seven studies, -thalassemia, 
sickle cell disease and G6PD were reported in the remaining two studies  
In most of the studies, the data reported the outcomes of national PMS outcomes 
and thus, it was obtained through longer follow-up period. Additionally, the program’s 
  
   
38 
 
outcomes in other studies were assessed in specific provinces. Examples of such countries 
included; UAE, Palestine, Iraq, Turkey and India. Furthermore, the studies also differed 
widely in terms of the implementation year of PMS program. In countries like Iran, Turkey 
and Palestine, mandatory PMS was implemented before 2004. On the other hand, in the 
countries of the Gulf region such as Saudi Arabia, Bahrain, UAE as well as Iraq, the 
program was mandated in 2004 or after. 
In conclusion, all the above-mentioned factors showed variations and weaknesses of the 
current available evidence, therefore; this variation should be taken into consideration 
while generalizing results to wider populations. Further, this should call for more well-
designed research in this area that could address factors leading for high risk marriages and 
strategies to prevent it.
  
   
38 
 
4.3 Risk of Bias 
Based on Hoy’s risk of bias (ROB) assessment criteria, of the 15 articles reviewed, 
six studies had low risk of bias (24,27,69–72) while seven had moderate risk of bias 
(5,25,63,64,67,68,74). On the other hand,  two studies had high risk of bias (62,73). In 
terms of external validity, 12 out of 15 studies were rated good as 3 of the 4 external validity 
criteria were met; however, none of the 15 studies got a full score of 4 on Hoy’s external 
validity assessment. In addition, none of the studies had a summary score of 10 on the risk 
of assessment tool (Figure 4).  
Nine studies (60%) had issues in the first domain that states whether a study’s target 
population is a close representation of national population in terms of relevant variables. 
Moreover, 3 studies (20%) had done poorly on the second domain of Hoy’s ROB tool, in 
terms of sampling frame as not being a true or close representative of the target population. 
In terms of random selection of sample or census data, three studies (20%) did not do well. 
In addition, five studies (33.3%) had done poorly in terms of minimizing non-response 
bias.  
On the other hand, all studies scored 100% in terms of fulfilling the first domain of 
internal validity i.e. data collected directly from the subjects. This is because the carrier 
status of the participants can be known only by taking blood sample directly from the 
patient and then sent to the laboratory. Furthermore, four studies (26.6%) had done poorly 
in terms of absence of an acceptable case definition.  
With regards to a valid and reliable study instrument, only two studies (13.3%) had 
issues, i.e. either the studies did not state it in the text, or it was unclear. Similarly, for 
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domain 8, the results showed that three studies (20%) did not use same data collection 
mode; some studies collected data from male patients while female partners were only 
invited if the males had a suspected testing result. 
 As for the domain nine that assesses if length of the shortest prevalence period was 
used, only one study (6.67%) rated poorly. The participants of the study (62) were required 
to recall events from their screening tests done two years ago. Lastly, in domain 10 of 
analysis, only one study (6.67%) did not do well where the numerator and denominator of 
interest were found unclear or inappropriate (Figure 5). 
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Figure 4: Summary of Risk of Bias for Each of the 15 Studies
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Figure 5: Percentages of Risk (low or high) across the Included Studies 
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4.4 Quantitative Synthesis 
The 15 studies that were included in the systematic review were also used for the 
meta-analysis. The studies reported different proportion of at-risk marriages among 
couples who underwent premarital screening program. From these 15 studies, the total 
population (couples) screened were 5,866,490 and there were 33,540 couples at risk. Out 
of these at-risk couples, 21,331 couples were cases who married their partners despite 
undergoing counseling sessions. 
 Table 4 shows the prevalence of at-risk marriages among “incompatible couples” 
from each study included in the systematic review and meta-analysis.  
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Table 4: Prevalence of At-risk Marriages among “Incompatible Couples” 
Author (year) Country Total 
couples 
screened 
(N) 
No. of 
couples  
at-risk,  
n (%) 
 
Couples at risk 
who married,  
n (%) 
Couples at risk 
who cancelled 
marriage,  
n (%) 
Alsuwaidi  
et al (2012) 
Saudi Arabia 4,444 582 478 (82.13%) 104 (17.87%) 
Memish et al 
(2011) 
 
Saudi Arabia 78,6070 
 
5370 3945 (73.46%) 
 
1425 (26.54%) 
 
Al Sulaiman et 
al (2010) 
Saudi Arabia 129 
 
129 127 (98.45%) 2 (1.55%) 
 
AlHamdan  
et al (2007) 
Saudi Arabia 207,333 
 
 
2375 2128 (89.60%) 
 
247 (10.40%) 
 
Zeinalian et al 
(2013) 
Iran 703,082 
 
5729 4497 (78.50%) 1232 (21.50%) 
 
Khorasani  
et al (2008) 
Iran 279,936 3329 1503 (45.15%) 1826 (54.85%) 
Karimi et al 
(2007) 
Iran 1,038,371 
 
 
5182 2798 (54%) 
 
 
2384 (46%) 
 
 
Samavat et al 
(2004) 
Iran 2,729,000 
 
10,298 5,431 (52.74%) 4867 (47.26%) 
Salama et al 
(2016) 
United Arab 
Emirates 
8,913 28 28 (100%) 0  
Almutawa  
et al (2009) 
Bahrain 1,070 30 17 (56.67%) 13 (43.33%) 
Al-Allawi et al 
(2013) 
Iraq 54,132 
 
130 105 (80.77%) 
 
25 (19.23%) 
 
 
Tarazi et al 
(2007) 
Palestine 19,712 122 56 (45.90%) 66 (54.10%) 
Guler et al 
(2010) 
Turkey 24,062 17 3 (17.65%) 14 (82.35%) 
Keskin et al 
(2000) 
Turkey 9,902 15 13 (86.67%) 2 (13.33%) 
Tamhankar et al 
(2009) 
 
India 334 204 202 (99.02%) 2 (0.98%) 
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Using Quality Effects Model (QEM), results of forest plot indicated an overall 
pooled prevalence of marriages among couples at-risk of 64% (95% CI: 49%, 78%) with 
significant heterogeneity (Cochran’s Q=3550, p-value <0.001, and I2=100%). We can see 
that the percentage of Higgin’s I2 value is very high and it reflects the proportion of 
variance(heterogeneity) observed between studies due to the presence of real differences 
in effect sizes. Forest plot in Figure 6 shows that the prevalence estimates of some 
individual studies were much higher than the overall pooled estimate. For example, UAE 
had the highest prevalence of 100% (94%, 100%), followed by India and Saudi Arabia 
with a prevalence of 99% (CI: 97%, 100%) and 98% (CI: 95%, 100%) respectively.   
On the contrary, the lowest prevalence was reported in Turkey which was 18% (CI: 3%, 
40%) as shown in Figure 6.  
Additionally, it was evident that the larger weights associated with some of the 
studies in the forest plot could be due to the method (QEM) used as well as large sample 
sizes from studies included in our meta-analysis. These large studies were conducted in 
Iran i.e. four studies (24,68–70) and two studies were carried out in Saudi Arabia (5,63).  
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Figure 6: Forest Plot for Pooled Estimate Using Quality Effect Model 
 
 
4.5 Heterogeneity Assessments 
As stated earlier, Cochran’s Q value and I2 percentage were very high; therefore, 
sub-group analysis was conducted to investigate the sources of heterogeneity and to 
investigate if Cochran’s Q value drops substantially and I2 value decreases. 
4.5.1 Sub-group Analysis 
Subgroup analysis was conducted to investigate any possible sources of 
heterogeneity that might contribute to considerable amount of heterogeneity in terms of 
Quality Effects
Prevalence
10.90.80.70.60.50.40.30.20.10
Study 
Guler et al (2010)  
Khorasani et al (2008)  
Tarazi et al (2007)  
Samavat & Modell (2004)  
Karimi et al (2007)  
Almutawa & Alqamish (2009)  
Overall 
Q=3550.05, p=0.00, I2=100%
Memish & Saeedi (2011)  
Zeinalian & Nobari (2013)  
Al-Allawi et al (2013)  
Alsuwaidi et al (2012)  
Keskin et al (2000)  
AlHamdan et al (2007)  
Al Sulaiman et al (2010)  
Tamhankar et al (2009)  
Salama & Saleh (2016)  
    Prev (95% CI)          % Weight
   0.18  (  0.03,  0.40)      0.4
   0.45  (  0.43,  0.47)     10.3
   0.46  (  0.37,  0.55)      0.7
   0.53  (  0.52,  0.54)     31.1
   0.54  (  0.53,  0.55)     15.8
   0.57  (  0.38,  0.74)      0.5
   0.64  (  0.49,  0.78)    100.0
   0.73  (  0.72,  0.75)     14.6
   0.78  (  0.77,  0.80)     15.5
   0.81  (  0.74,  0.87)      0.7
   0.82  (  0.79,  0.85)      1.9
   0.87  (  0.64,  1.00)      0.4
   0.90  (  0.88,  0.91)      6.6
   0.98  (  0.95,  1.00)      0.3
   0.99  (  0.97,  1.00)      0.7
   1.00  (  0.94,  1.00)      0.4
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Cochran’s Q and Higgin’s I2 value. Included studies were separated through specific 
characteristics which were pre-specified in the protocol of review before inspecting the 
results of our meta-analysis. Studies were divided based on different categories such as risk 
of bias (low or intermediate), region, income level (high or middle), ethnicity (Arab vs 
non-Arab), sample size, study design, consanguinity proportion, diseases screened (-
thalassemia or SCD and -thalassemia both), prenatal diagnosis data, and year of 
implementation of the program. 
First, subgroup analysis was conducted between low risk and intermediate risk 
studies. The pooled prevalence estimate for low risk studies was 52% (CI: 46%, 57%) as 
compared to 79% (CI: 69%, 88%) for intermediate risk of bias studies. The Cochran’s Q 
dropped to 89 (p-value<0.001) and an I2 value of 94% for low risk studies while it was 
378.5 (p-value<0.001) for intermediate risk studies with an I2 value of 98%. Both numbers 
of Cochran’s Q were less than the main pooled estimate’s Q value (Q=3550, p-
value<0.001).   
Secondly, subgroup analysis was conducted according to region/country. The 
prevalence was highest for Gulf countries; it was 80% (CI: 64%, 94%) with a Q-value of 
382 (p-value<0.001) and I2 value of 99%. On the other hand, for Levant countries, the 
pooled prevalence was 65% (CI: 27%, 97%) with a drastic reduction in Cochran’s Q value 
(Q=34.45, p-value<0.001) and I2 value 97%. For Iran, the pooled prevalence was 58% (CI: 
42%, 73%) with the highest Cochran’s Q value (Q=1506.7, p-value<0.001; I2 value 
=100%) compared to other regions. The lowest pooled prevalence was reported for Turkey 
i.e. 50% (CI:0%, 100%) with a substantial drop in Cochran’s Q (Q=16.6, p-value<0.001) 
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and I2 value of 94%. Lastly, for India, the pooled prevalence was 99% (CI: 97%, 100%).  
For study design subgroup, there was a substantial drop in Cochran’s Q in the 
subgroup of cross-sectional i.e. it was 71.75 (p-value<0.001) with I2 value of 96% and 
pooled prevalence of 90% (CI: 71%, 100%). However, for retrospective population studies, 
the pooled estimate was 61% (CI: 47%, 74%) with high Cochran’s Q value of 2050 (p-
value<0.001) and I2 value 100% which indicates that the source of such high heterogeneity 
was possibly due to studies with long term outcome assessment of the program.  
Moreover, studies where the program was implemented before 2004 had a lower 
pooled prevalence of at-risk marriages i.e. 58% (CI: 42%, 73%) and I2 value of 100% 
compared to countries where the program was implemented in 2004 or after with a pooled 
prevalence of 80%(CI: 65%, 93%). For the second subgroup (2004), there was a 
substantial drop in Cochran’s Q, which was 382 (p-value<0.001) and I2 value of 98%.  
When studies were categorized based on income level, the pooled prevalence of at-
risk marriages among high-income countries was 80% (CI: 64%, 94%) with a considerable 
reduction in Cochran’s Q (Q=382, p-value <0.001) and I2 value 99%. On the other hand, 
middle-income countries had lesser pooled estimate as compared to high income, i.e. 58% 
(CI: 42%, 75%) with a Cochran’s Q of 1846 (p-value<0.001) and I2 value 100%.  
Furthermore, four of the included studies also reported consanguinity among 
couples at-risk. Two of those studies (66,72) reported consanguinity rate of 13.33% and 
39.2% respectively. While the remaining two studies (61,64) had consanguinity rate of 
55.67% and 70% respectively. Thus, studies were categorized into less than 50% 
consanguinity rate and those with 50% or more. The results indicated that those with less 
  
   
48 
 
than 50% consanguinity proportion had a pooled estimate of 81% (CI: 75%, 87%) with a 
Cochran Q value of 0.15 (p-value=0.70) and I2 of 0%. Consequently, no heterogeneity was 
detected between studies of less than 50% consanguinity proportion. On the other hand, 
studies with consanguinity rate of 50% or greater had an overall pooled prevalence of 83% 
(CI: 41%, 100%), with a Cochran’s Q value of 12.8 (p-value<0.001) and I2 value 92%.  
Studies were also categorized based on sample sizes (<2000 and 2000 couples at-
risk). The prevalence was higher in studies with a sample size less than 2000 i.e. 81% (CI: 
59%, 98%) compared to those with 2000 couples, where the prevalence of at-risk 
marriages was 63% (CI: 48%, 77%). There was a substantial drop in Cochran’s Q value 
for studies with less than 2000 sample size i.e. it was 257.1 (p-value<0.001) and I2 value 
of 97% indicating that most of the heterogeneity is coming from large studies with sample 
size 2000 or greater (Cochran’s Q value= 2999, p-value<0.001 and I2 value= 100%).  
In terms of diseases screened among the study population, there were two 
categories i.e. those screened only for -thalassemia and those that screened for both -
thalassemia along with SCD. The results from sub-group analysis showed a prevalence of 
58% (CI: 41%, 75%) among couples screened for only -thalassemia compared to 79% 
(CI: 63%, 93%) for studies that screened both -thalassemia and SCD. There was a 
substantial drop in Cochran’s Q value in the second subgroup that assessed SCD and -
thalassemia i.e.  the value was 411(p-value<0.001) and I2 value of 98%. 
Furthermore, studies were also grouped according to ethnicity i.e. Arab vs non-
Arab. Pooled prevalence estimate of Arab countries was found to be 79% (CI: 63%, 93%) 
which was higher than non-Arab countries where it was 58% (CI: 41%, 75%). Furthermore, 
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there was a substantial drop in Cochran’s Q value for Arab subgroup with a Q value of 444 
(p-value<0.001) and I2 value 98%.  
With regards to prenatal diagnosis data availability, studies were group into those 
where PND was available, and those where PND was not present or prenatal diagnosis was 
not done. The pooled prevalence for PND data subgroup was 59% (CI: 42%, 75%) while 
it was higher for studies where PND was not available with a pooled prevalence of 78% 
(CI: 60%, 93%). It could probably be explained by the presence of efficient PMS system 
as well as more utilization of PND services by the general public. There was a substantial 
drop in Cochran’s Q value for second subgroup (Q=473, p-value<0.001) and I2 value 99%.  
Similarly, studies were also categorized into four levels based on outcome 
assessment years or length of study period. For countries with less than or equal to two 
years outcome assessment (or study period), the prevalence was highest compared to other 
categories i.e. 86% (CI: 70%, 98%), while for studies with three to five years outcome 
assessment, it was 54% (CI: 0%, 100%). The other categories were 6-10 years with pooled 
prevalence of 65% (CI: 44%, 84%) and 11 to 20 years with pooled prevalence of 66% (CI: 
29%, 97%). There was a substantial drop in Cochran’s Q value in the first three sub-
categories. For first category, it dropped to 103 with p-value<0.001 with I2 value 96%.; for 
second category it dropped to 390 (p-value<0.001) with I2 value 99%; whereas for third 
category, it dropped to 474 (p-value<0.001) and I2 value 100%..   
4.5.1.2 Testing Significance between Subgroups: 
In order to observe the statistically significant differences between subgroups, 
overlapping of confidence intervals were compared. A study (75) conducted by Cumming 
(2009) stressed the importance of accurate reporting of 95% confidence interval (CI) bars 
  
   
50 
 
of two independent means as researchers misinterpret the overlapping results. In other 
words, the author clarified that if two confidence intervals nearly touch, p-value can be 
about 0.01. Additionally, p-value can only reach to 0.05 when about half the length of one 
confidence interval arm overlaps with the arm of other CI (75). 
 Figures 7-18 below show the confidence intervals for all subgroups mentioned 
above to inspect statistically significant differences between the subgroups. This helps in 
understanding factors that could be associated with the heterogeneity observed in our study.  
The risk of bias groups were compared (Figure 7), and there was statistically significant 
difference between studies with low risk and intermediate risk of bias.  
With respect to region, India was statistically significantly different than other 
regions (Figure 8). Additionally, subgroups like ethnicity (Arab/non-Arab), income level 
and diseases screened were marginally significant (Figures 9, 10 &15). Confidence 
intervals of sample size and PND data availability showed overlapping (Figures 11 &12), 
i.e. overlapping by more than half the length of one CI arm; therefore, there was no 
significant difference between subgroups of these factors. In contrast, in subgroups 
pertaining to length of outcome assessment, studies with period 2 years or less were 
significantly different than other categories (Figure 13). 
Similarly, there was statistically significant difference in studies with less than 50% 
consanguinity compared to those with 50% or greater (Figure 14). The remaining 
subgroups significantly different were; study design (Figure 16) and implementation year 
(Figure 17).   
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Figure 7: Confidence Interval Plot for Risk of Bias Subgroup 
 
 
 
Figure 8: Confidence Interval Plot for Region/country Subgroup 
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Figure 9: Confidence Interval Plot for Ethnicity Subgroup 
 
 
 
 
Figure 10: Confidence Interval Plot for Income Level Subgroup 
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Figure 11: Confidence Interval Plot for Sample Size Subgroup 
 
 
 
 
Figure 12: Confidence Interval Plot for PND Subgroup  
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Figure 13: Confidence Interval Plot for Length of Outcome Assessment (years) Subgroup 
 
 
 
Figure 14: Confidence Interval Plot for Consanguinity Proportion Subgroup 
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Figure 15: Confidence Interval Plot for Diseases Screened Subgroup 
 
 
 
 
Figure 16: Confidence Interval Plot for Study Design Subgroup 
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Figure 17: Confidence Interval Plot for Implementation Year Subgroup 
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sizes, the observed effect sizes would still vary across studies due to presence of the real 
differences in study population in terms of factors like age, length of follow-up and 
interventions received (76). 
For the purpose of this study, we used REM as a sensitivity analysis, but our main 
findings were based on QEM. Table 5 illustrates comparison between Quality and Random 
Effects models in terms of pooled prevalence and heterogeneity by using Higgin’s value 
i.e. I2.  
Apparently, the pooled prevalence of at-risk marriages using QEM and REM was 64% (CI: 
49%, 78%) and 75% (CI: 66%, 83%) respectively. It was found that the I2 value were 
almost similar for both models in all subgroups. Overall, there were lack of wide 
differences between the prevalence values yielded by the two models and this supports the 
validity of our results in this meta-analysis. Examples of subgroups with the least 
differences in prevalence in REM and QEM models included; region, income level, 
ethnicity, prevalence, diseases screened, study design, sample size and implementation 
year.
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Table 5: Sub-group Analysis of Included Studies using QEM and REM 
  
Quality Effects Model 
 
Random Effects Model 
 
 No. of Studies 
(couples at risk) 
Prevalence  
(95% CI) 
I2 No. of Studies 
(couples at 
risk) 
Prevalence (95% CI) I2 
 
 
 
All eligible studies 
 
15 (33,540) 64% (CI: 49%, 78%) 100% 15 (33,540) 75% (CI:66%, 83%) 100% 
Risk of Bias 
Low ROB 
Intermediate ROB 
 
6 (18,871) 
7 (14,336) 
 
 
52% (CI: 46%, 57%) 
79% (CI: 69%, 88%) 
 
94% 
98% 
 
6 (18,871) 
7 (14,336) 
 
 
69% (CI:61%, 78%) 
80% (CI:73%, 86%) 
 
99% 
98% 
Region/country 
Gulf countries 
Levant countries 
Iran 
Turkey 
India 
 
6 (8514) 
2 (252) 
4 (24,538) 
2 (32) 
1 (204) 
 
80% (CI: 64%, 94%) 
65% (CI: 27%, 97%) 
58% (CI: 42%, 73%) 
50% (CI: 0%, 100%) 
99% (CI: 97%, 100%) 
 
99% 
97% 
100% 
94% 
- 
 
6 (8514) 
2 (252) 
4 (24,538) 
2 (32) 
1 (204) 
 
87% (CI: 77%, 94%) 
64% (CI: 26%, 97%) 
58% (CI: 43%, 72%) 
52% (CI: 0%, 100%) 
99% (CI: 97%, 100%) 
 
 
99% 
97% 
100% 
94% 
- 
Ethnicity 
Arab 
Non-Arab 
 
 
8 (8,766) 
7 (24,774) 
 
79% (CI: 63%, 93%) 
58% (CI: 41%, 75%) 
 
98% 
100% 
 
8 (8,766) 
7 (24, 774) 
 
82% (CI: 72%, 90%) 
66% (CI: 53%, 77%) 
 
98% 
100% 
Income level 
High Income 
Middle Income 
 
6 (8,514) 
9 (25,026) 
 
80% (CI: 64%, 94%) 
58% (CI: 42%, 75%) 
 
99% 
100% 
 
6 (8,514) 
9 (25,026) 
 
87% (CI:77%, 94%) 
65% (CI:55%, 76%) 
 
99% 
100% 
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Quality Effects Model 
 
Random Effects Model 
 
 
 
No. of Studies 
(couples at risk) 
Prevalence  
(95% CI) 
I2 No. of Studies 
(couples at risk) 
Prevalence  
(95% CI) 
I2 
 
 
Implementation year 
Before 2004 
2004 and after 
 
7 (24,692) 
7 (8,644) 
 
58% (CI: 42%, 73%) 
80% (CI: 65%, 93%) 
 
100% 
98% 
 
7 (24,692) 
7 (8,644) 
 
55% (CI: 43%, 67%) 
86% (CI: 77%, 93%) 
 
100% 
98% 
 
 
Length of Outcome 
Assessment (years) 
2 years 
3-5 years 
6-10 years 
11-20 years 
 
 
 
5 (3133) 
5 (10,769) 
3 (10,580) 
2 (9,058) 
 
 
 
86% (CI: 70%, 98%) 
54% (CI: 0%, 100%) 
65% (CI: 44%, 84%) 
66% (CI: 29%, 97%) 
 
 
 
96% 
99% 
100% 
100% 
 
 
5 (3133) 
5(10,769) 
3 (10,580) 
2 (9,058) 
 
 
78% (CI: 66%, 89%) 
76% (CI: 48%, 98%) 
77% (CI: 61%, 91%) 
63% (CI: 27%, 95%) 
 
 
96% 
99% 
100% 
100% 
Consanguinity 
(among at-risk) 
<50% 
50% 
 
 
 
2 (145) 
2 (610) 
 
 
81% (CI: 75%, 87%) 
83% (CI: 41%, 100%) 
 
 
 
0% 
92% 
 
 
2 (145) 
2 (610) 
 
 
 
81% (CI: 74%, 87%) 
93% (CI: 69%,100%) 
 
 
 
0% 
92% 
Diseases screened 
-thalassemia 
-thalassemia & 
SCD 
 
 
6 (24,864) 
9 (8,676) 
 
 
58% (CI: 41%, 75%) 
79% (CI: 63%, 93%) 
 
100% 
98% 
 
6 (24,864) 
9 (8,676) 
 
66% (CI: 53%, 78%) 
81% (CI: 72%, 89%) 
 
100% 
98% 
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Quality Effects Model 
 
 
Random Effects Model 
 
 No. of Studies 
(couples at risk) 
Prevalence (95% CI) I2 No. of Studies 
(couples at 
risk) 
Prevalence (95% CI) I2 
 
 
Prenatal Diagnosis  
Yes 
No 
 
 
7 (24,887) 
8 (8,653) 
 
59% (CI: 42%, 75%) 
78% (CI: 60%, 93%) 
 
100% 
99% 
 
7 (24,887) 
8 (8,653) 
 
73% (CI: 61%, 83%) 
77% (CI: 66%, 86%) 
 
100% 
99% 
Study Design 
Cross sectional 
Retrospective 
 
4 (2,738) 
10 (30,220) 
 
90% (CI: 71%, 100%) 
61% (CI: 47%, 74%) 
 
96% 
100% 
 
4 (2,738) 
10 (30,220) 
 
91% (CI: 80%, 99%) 
65% (CI: 56%, 74%) 
 
96% 
100% 
 
Sample Size 
<2000 
2000 
 
9 (1,257) 
6 (32,283) 
 
81% (CI: 59%, 98%) 
63% (CI: 48%, 77%) 
 
97% 
100% 
 
9 (1,257) 
6 (32,283) 
 
80% (CI: 64%, 93%) 
67% (CI: 53%, 79%) 
 
 
97% 
100% 
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4.6 Sensitivity Analysis 
The primary analysis of overall pooled prevalence of at-risk marriages among 
couples receiving premarital counseling was repeated using QEM by including only low 
risk studies in order to estimate its prevalence. Hence, a total of 6 low-risk studies 
(24,27,69–72) were included. The results indicated that the pooled estimate of high-quality 
studies was 52% (CI: 46%, 57%). In addition, heterogeneity decreased by a considerable 
amount in Cochran’s Q, i.e. 89.55 (p-value<0.001) and I2 value of 94% which was still 
high. (Figure 18) 
Furthermore, when 3 of the small-size studies (27,71,72) were excluded from this 
plot, the overall pooled estimate did not change, i.e. 52% (CI: 47%, 57%). Cochran’s Q 
value reduced further (Q= 72.65; p-value<0.001) with an I2 value of 97%. (Figure 19)  
 
 
 
 
Figure 18: Forest Plot Using Sensitivity Analysis (with Low-Risk Studies) 
Quality Effects
Prevalence
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Overall 
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Karimi et al (2007)  
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Figure 19: Forest Plot using Sensitivity Analysis (Large Studies with Low Risk) 
 
 
4.7 Publication Bias 
The publication bias, of the included studies in our meta-analysis, was examined 
using Funnel plot and Doi plot. Funnel plots show scatter plots of the study’s effect 
estimates against sample size, could be useful in assessing the validity of meta-analyses. It 
is based on increase in the precision in estimating the underlying effect size with increase 
in the sample size of the study (77). This means that distribution of small studies scatters 
widely at the bottom of the graph while larger studies will be narrow at the top of the graph. 
When there is publication bias, the funnel plots are usually skewed and asymmetrical (77). 
Hunter et al (2014) argued that classical funnel plots are not reliable methods for 
proportion measures (78). He, therefore, suggested to provide an alternative approach 
which are funnel plots including study size against log-odds, thus it could be more accurate 
estimate for prevalence studies. Funnel plot in Figure 20 shows that it is asymmetrical 
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mostly to the right side. In addition, due to subjective nature of scatter plots in funnel plots, 
a new method of observing publication bias was developed through a Doi plot. It replaces 
the conventional scatter plot with a normal quantile plot that makes up the limbs of plot 
through the study data (60). It provides an LFK index that quantifies the extent of 
asymmetry i.e. if value of LFK index is closer to zero, the Doi plot would be symmetrical. 
On the other hand, values of LFK beyond -1 and +1 are regarded as asymmetrical (60). As 
shown in Figure 21, Doi plot indicates asymmetry with an LFK value of 4.94 demonstrating 
publication bias. 
When sensitivity analysis was done only for studies with low risk of bias (six 
studies), it was apparent from the plot, that there was no major publication bias. Small 
studies are expected to scatter more widely near the x-axis, i.e. scattered on the base of the 
inverted funnel (77). On the other hand, large studies are presented on the top as shown in 
Figure 22. The funnel plot shows that the large studies are close together towards the top 
of the inverted funnel thus indicating no publication bias. When Doi plot was assessed, 
there was no asymmetry with an LFK value of 0.96 thus concluding no publication bias 
(Figure 23).  
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Figure 20: Funnel Plot Assessing Publication Bias (All 15 Studies) 
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Figure 21: Doi Plot Assessing Publication Bias (All 15 Studies) 
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Figure 22: Funnel Plot for Sensitivity Analysis (Only Low Risk Studies) 
 
 
 
 
Figure 23: Doi Plot for Sensitivity Analysis (Only Low-Risk Studies) 
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CHAPTER 5: DISCUSSION 
This is the first meta-analysis that estimated the prevalence of at high-risk 
marriages among high risk couples of hemoglobinopathies globally and regionally. In our 
study, the estimated global prevalence of at high-risk marriage of hemoglobinopathies was 
64%; however, this varies widely across different regions and income level.  
Our results revealed that high-income countries including Saudi Arabia and UAE 
had higher prevalence of at-risk marriages (pooled prevalence of 80%) compared to middle 
income countries (i.e. 58%) but results were not significant. In addition, based on region, 
estimates where the program was implemented before 2004 i.e. Iran, Turkey and Palestine 
had lower pooled prevalence of at-risk marriages compared to other countries of GCC and 
India.  It could probably be explained by the fact that countries, where the PMS programs 
were implemented before 2004 (from 1995 to 2000), might have perceived the issue of 
high prevalence of at-risk marriages earlier as compared to countries where it was 
implemented in 2004 and after. Therefore, some amendments could have been made to the 
existing programs to increase the compliance rates. 
The results of this meta-analysis are consistent with a scoping review (3) conducted 
by Saffi & Howard (2015) to evaluate the effectiveness of Premarital screening (PMS) 
programs in the Middle East. It concluded that PMS programs were not successful in 
reducing at-risk marriages by at least 65% (3). The scoping review by Saffi & Howard 
(2015) is based on studies in the Middle East region including narrative reviews. 
Furthermore, scoping review stated that the percentage of cancellation of at-risk marriages 
due to mandatory premarital screening was 53% in Turkey (3).  
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Similarly, evidence from review study in Jordan showed that PMS program 
discouraged 40% of at-risk marriages (16). In contrast, another review study in Jordan 
indicated that out of 48 at-risk couples identified in 2006, only three (6%) of them cancelled 
marriage plans (79). Moreover, after the implementation of PMS program in Saudi Arabia, 
about half of at-risk couples (51.9%) cancelled their marriage plans while the remaining 
half (48.1%) proceeded with their marriages (63). Similarly, results from a cost analysis 
study (80) in the province of West Azerbaijan in Iran show that during the period 2002-
2006, the average rate of marriage cancellation among at-risk couples was 53% with a 
minimum rate of 38% in 2003 and a maximum rate of 69% in year 2006.  
In light of the above mentioned problem, a recent study published in 2018 provided 
recommendations to reduce the incidence of genetic diseases on a national level (81).  
According to this study, health promotion and disease prevention efforts should be 
improved for those able to transmit genetic disorders. A follow up program after marriage 
is needed to ensure that couples acquire sufficient knowledge (81).  
Similarly, data from the studies included in our meta-analysis indicates that there 
is still a wide gap to be filled to turn these programs effective. These programs are proved 
to be successful in screening the vast majority of eligible individuals and identifying the 
couples at risk while providing them education. However, it remains challenging in terms 
of successful reduction in the incidence of hemoglobinopathies (beta-thalassemia and 
sickle cell disease) due to inadequate compliance of at-risk couples with the counseling 
decision. These could be due to various factors such as culture, religion, preference of 
consanguinity among certain populations, quality of counseling sessions provided during 
PMS programs as well as less awareness of genetic diseases like hemoglobinopathies and 
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its severity among the general public.  
The results of sub-group analysis in this meta-analysis showed that countries where 
the program was implemented before 2004 had a pooled prevalence of 58% (CI: 42%, 
73%). This percentage is lower than those countries where the program was implemented 
in 2004 or after (pooled prevalence was 80% with CI: 65%, 93%). The examples of 
countries where it was implemented before 2004 are Iran, Turkey, Palestine (Gaza strip). 
On the other hand, it may take some time for countries in Gulf, Iraq and India to reduce the 
percentage of at-risk marriages. 
In terms of investigating the reasons of marriage among high risk couples, a follow 
up study in Saudi Arabia (62) revealed that ”previous agreement and family pressures” was 
the most frequently reported reason, and was reported by 48% of the participants. 
Similarly, it was followed by “the only one in my mind” and was reported by 34% of the 
participants. Additionally, the majority of these participants had received counseling from 
general physicians, while a substantial number of couples had received counseling from 
other staff who did not have adequate knowledge of the diseases screened. On the other 
hand, some participants did not receive counseling at all (62).  
Moreover, a study in Iran (68) evaluated the impact of premarital screening 
program over two decades. It reported the frequency of causes for the major -thalassemia 
births that happened during 1997-2010. It was stated that 51.4% of the reported major beta-
thalassemia cases were due to marriages that happened before starting the program. On the 
other hand, 14.7% of the cases were due to culture-related reasons while 9.2% of the cases 
were due to genetic counseling inadequacy(68).  
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The presence of prenatal diagnosis during pregnancy is another factor that impacts 
the decision of at-risk couples (82). For example, Cyprus had started the screening of beta-
thalassemia and genetic counseling in 1980 but record shows that as they started prenatal 
diagnosis program in 1984, the number of affected births dropped dramatically from 18-
20 to 6-7 per year (82).   
Similarly, it has been estimated (24) that in Iran before legalizing the prenatal 
diagnosis and pregnancy termination, about half of the at-risk couples proceeded with the 
marriage while the other half separated. The separation of these high-risk couples helped 
in reducing the incidence of -thalassemia (24).This indicates that the access of population 
to services like PND and pregnancy termination will more likely have a positive impact on 
reduction of hemoglobinopathies. On the other hand, this might not always be a positive 
factor towards reduction in the incidence of hemoglobinopathies. For example, in Saudi 
Arabia, there has been little change in the incidence of -thalassemia, and the practice of 
prenatal diagnosis and pregnancy termination has not been widely spread. However, it is 
speculated that the incidence of thalassemia in Saudi Arabia may reduce, as pre-
implantation genetic diagnosis is being viewed as a popular alternative (21). 
The results of our meta-analysis indicated that prevalence of at high-risk marriages 
was lower in countries where prenatal diagnosis was provided to couples i.e. 59% (CI:42%, 
75%) compared to countries where it was not provided, or no data was available i.e. 78% 
(CI: 60%, 93%). For example, studies from Iran, Turkey, and Iraq had reported PND data 
and the prevalence of at high-risk marriages were 58%, 50% and 81% respectively.  
The approach of general population to actively participate in seeking services like 
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PND also depends on the country’s prevailing healthcare systems. In a poor resource 
setting like Nigeria, that has a high disease burden in terms of SCD and other 
hemoglobinopathies, a recent study (83) reported that due to huge financial implications 
for raising a SCD-affected child which is even worsened by co-existence of health care 
financing based on out-of-pocket expenditure, SCD heterozygous women(63%) most 
commonly preferred the termination of pregnancy(TOP) after undergoing genetic 
counseling and testing.  Nonetheless, in another study (84) when the attitudes of Nigerian 
at-risk couples for having offspring with SCD were evaluated, it was shown that two-third 
(66.67%) of them would call off their marriage if their blood results were not compatible. 
In other words, this implies that around 33.3% of couples would still proceed with the 
marriage decision after knowing their carrier status. This proportion is found much lower 
in contrast to our meta-analysis estimate in terms of middle income (lower or upper middle) 
countries, where the prevalence of at-risk marriages was 58% (CI: 42%, 75%) as compared 
to high-income countries with a much higher prevalence of 80% (CI: 64%, 94%). 
On the other hand, in China where common diseases extensively screened are 
hemoglobinopathies, hepatitis B virus (HBV), HIV including physical examination done 
for all prospective couples. Interestingly, PMS programs at the national level is seen as an 
ideal forum for important health interventions(85). For example, it helps in increasing the 
uptake of folic acid by premarital women thereby decreasing the prevalence of neural tube 
defects. Also, PMS is seen as a good educational opportunity to reduce the exposure of 
future children to second-hand smoking by their fathers (85). 
Nonetheless, in a region like Middle East, there could be several reasons for the 
poor performance of PMS programs. In this regards, the scoping review done on the Middle 
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East countries (3) discussed few main reasons; i.e. poor timing of the screening, combined 
with lack of knowledge related to inherited diseases as well as religious and sociocultural 
concerns that all play huge role in discouraging at-risk marriages(3).  
Literature from different countries including developed world still indicate a gap in 
population’s awareness regarding hemoglobinopathies. A survey(86) was conducted 
among British pregnant women who had undergone carrier testing to study their awareness 
of testing before the national antenatal screening program was being implemented. The 
study revealed that 77.4% of women had not been informed about thalassemia carrier 
screening, while 85.8% of women actually wanted to have been informed(86). Similar 
results were also shown in United States of America, as pregnant women had lack of 
awareness regarding genetic testing, and even if they had undergone carrier testing 
previously, it was ascertained that they were not able to recall undergoing the test (87).  
Nonetheless, Bahrain is one of the Gulf countries where increased efforts are 
being diverted towards educating public about genetic disorders. A student-screening 
project was initiated in 1998 to screen students before they leave school. The aim of this 
project was mainly to raise awareness among students regarding hereditary diseases by 
providing students the results of their blood tests along with a booklet containing 
information about the disease he/she carries (88). Such project has contributed in 
increasing awareness among family of carrier students. In addition, the results of a study 
in Bahrain (88) indicated that there was a birth prevalence of 0.9% for sickle cell disease 
in 2002, which had decreased by almost 60% since 1984-1985 (2.1%). This was the first 
time in Bahrain where a prevalence of less than 1% was reported and if such trend 
continued, Bahrain would be the first country in the Gulf region to successfully eradicate 
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sickle cell disease in near future (88). 
In the same way, the Cyprus Thalassemia Control Program has been successful in 
reducing the birth prevalence of -thalassemia major through several important measures 
that were taken in the country. These include; health education, carrier screening, 
premarital counseling and prenatal diagnosis. The successful outcomes could be replicated 
in other countries following similar approach or adopting same measures (88). 
To increase the success rate of PMS programs, another study (89) stressed the 
importance of quality of counseling sessions due to inadequate standardized guidelines. 
Data from this study showed that the lower compliance of at-risk couples to the counseling 
was associated with less awareness about these genetic diseases among public. A genetic 
counseling session consisting of 15-20 minutes is insufficient for couples who are informed 
of these diseases just before phlebotomy or upon receiving the results (89).   
It is also recommended to well-establish the meaning of the “carrier status” among 
the public before the age of marriage(89). For example, Scriver’s group achieved a 90-95% 
success in informing high school students through using the cooperation of organizations 
like governmental, non-governmental organizations, community leaders, local health 
personnel, as well as voluntary screening and genetic counselling over a 20-year span in 
Canada (90). 
Additionally, in Saudi Arabia, the majority of counseling clinics are run by 
pediatricians due to limited number of qualified genetic counselors. Such sessions are 
provided in the form of one-to-one counseling after a couple receives an “incompatible 
status certificate”. Furthermore, there are no existing standardized guidelines for the 
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content of such premarital counseling sessions and materials (91).  
In short, high-quality genetic counseling and more effective psychological support 
system are needed for the at-risk couples to ensure that they have comprehensive awareness 
of genetic risks of future offspring, if they decide to proceed with the marriage. Such efforts 
should be combined with improvement in other community sectors such as education 
through high schools, where students can attain high knowledge regarding such genetic 
diseases before the age of marriage. In other words, comprehensive life cycle approaches 
would more likely prove to be effective in reducing and preventing at-risk marriages, which 
can lead to reduction the incidence of hemoglobinopathies.  
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CHAPTER 6: IMPLICATIONS, STRENGTHS & LIMITATIONS 
6.1 Implications   
Findings of this research have several important implications. It provided a better 
understanding of high prevalence of at-risk marriages for “carrier couples” who underwent 
PMS and counseling with certain populations reporting higher prevalence as compared to 
others that had well-established programs with specialized counselors. Some important 
factors that could be associated with higher prevalence include ethnicity (being Arab), 
awareness of PMS, implementation of PMS or whether PMS is accessible, specifically in 
terms of financial constraints, whether the program is voluntary or mandatory for pre-
couples in the country. Understanding such factors open ways for new research that 
explores these factors in details. Further, investigating factors associated with high-risk 
marriage could lead to identification and implementation of policies to reduce this risk and 
its costly consequences to the family and society, in terms of genetic diseases. 
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6.2 Strengths 
To the best of our knowledge, this is the first meta-analysis that described the 
prevalence of at-risk marriages for hemoglobinopathies using a sound methodological 
research design. It followed the recommendations of PRISMA statement as well as 
MOOSE guidelines. 
Moreover, it is worth noting that the risk of bias assessment for included studies 
was done by two independent reviewers in a blinded fashion. Additionally, QEM was used 
which takes into consideration the risk of individual study and hence provides more 
accurate pooled estimates as compared to REM. Most of the studies included in this meta-
analysis were of large sample sizes which increases the precision of the study estimates. 
Lastly, sensitivity analysis was also done to calculate the pooled estimates based on low 
risk studies only and it indicated no major publication bias. 
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6.3 Limitations 
This study has several limitations, there was a lack of studies outside the Middle 
East region so that the prevalence of at-risk marriages could be mostly representing the 
Middle East region, especially, all large studies were from Saudi Arabia and Iran.  
However, this is in line with consanguineous marriages which are common in the region, 
with the highest consanguineous marriages rates in the world reported in the Arab 
countries.  
Another limitation was that some countries offer voluntary premarital screening 
programs while it is mandatory in others. Useful comparisons could have been made for 
the prevalence of at-risk marriages of this group with the mandatory program group as part 
of subgroup analysis, but we could not do it due to lack of studies. Moreover, there was 
significant heterogeneity across studies that could pose threat or bias our pooled estimates 
as indicated by heterogeneity tests and Higgin’s I2 percentage.  
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CHAPTER 7: RECOMMENDATIONS AND CONCLUSION 
7.1 Recommendations 
More high-quality studies addressing the prevalence of at-risk marriages are 
required as well as studies on possible factors contributing to couples complying less with 
the counseling provided. This will help us analyze those factors by subgroups analysis and 
provide deeper understanding regarding this issue.  
Another recommendation is increasing the awareness of public on 
hemoglobinopathies, especially, in the Gulf countries at the school levels and through 
community campaigns so that couples are well-informed of future risk of 
hemoglobinopathy-affected children. This could be more useful approach compared to 
obtaining all information right before the marriage when arrangements are already made.   
Qualified genetic counselors at specialized clinics have to be available for at-risk 
couples to provide enough education regarding the financial and emotional burden of such 
genetic diseases. Finally, more epidemiological studies are needed in order to explore 
underlying reasons and possible interventions to reduce this high prevalence of at-risk 
marriages, particularly, in the Middle East region. 
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7.2 Conclusion  
The World Health Organization (WHO) estimates that 2.9% of the world’s 
population is affected by beta-thalassemia. This gives rise to many challenges on the health 
care system and consumption of resources globally. In the Middle East region, the burden 
of several recessive genetic disorders especially beta-thalassemia is higher compared to 
other regions. Additionally, most of these genetic diseases are life-threatening and are 
expensive to treat as well.  
Therefore, several countries in the region have implemented mandatory premarital 
screening programs in order to reduce at-risk marriages and thus, the prevalence of such 
diseases.  
This study was conducted in order to systematically review the global burden of at-
risk marriages that is a major factor in contributing to higher prevalence of 
hemoglobinopathies and therefore, quantify the global prevalence using the statistical 
approach of meta-analysis. The results of the current study indicated that about 64% of at-
risk couples proceeded with the marriage despite receiving the counseling sessions. 
Similarly, most prevalence estimates of the individual studies were higher than the overall 
pooled estimate, which indicates a serious public health problem.  
However, one of the limitations of our study is that significant heterogeneity was 
found across studies that could pose threat to the pooled estimates meaning that there is 
uncertainty in the estimated prevalence and well-designed research is needed in this area 
for accurate estimate. Regardless, apparently, high-risk marriages is a problem that should 
be addressed at individual and societal/ cultural levels. Some strategies could include 
counseling sessions with specialized genetic counselors as well as promoting educational 
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campaigns to increase knowledge and awareness about the risk of hemoglobinopathies 
among general population before the age of marriage. 
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